Familial fibrocystic pancreatic atrophy with endocrine cell hyperplasia and pancreatic carcinoma
Reviewer: Deepali Jain, M.D. (see Reviewers page)
Revised: 6 December 2012, last major update August 2012
Copyright: (c) 2001-2012, PathologyOutlines.com, Inc.
● Autosomal dominant, high penetrance, associated with diabetes mellitus, exocrine pancreatic insufficiency, characteristic imaging abnormalities
● Fibrosis, intraductal calcifications, microcysts
● Lobulocentric patchy to diffuse fibrocystic changes (collagenization, microcysts) with stromal fibrosis, acinar atrophy, endocrine cell hyperplasia resembling nesidioblastosis, multifocal PanIN 2-3
● Minimal background pancreatitis
● Malignancies often unusual histology: small cell, giant cell anaplastic, cystadenocarcinoma (Am J Surg Pathol 2001;25:1047)
End of Pancreas > Tumors > Familial fibrocystic pancreatic atrophy with endocrine cell hyperplasia and pancreatic carcinoma
This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must be interpreted in the context of a patient's clinical data using reasonable medical judgment. This website should not be used as a substitute for the advice of a licensed physician.
All information on this website is protected by copyright of PathologyOutlines.com, Inc. Information from third parties may also be protected by copyright. Please contact us at [email protected] with any questions (click here for other contact information).